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Background/aim: The aim of this study was to investigate the presence of Encephalitozoon intestinalis in different patient groups
consisting of immunocompromised and immunocompetent individuals.
Materials and methods: The stool samples of 100 patients consisting of 25 patients receiving chemotherapy and with acute gastrointestinal
complaints, 25 with bone marrow transplant and acute gastrointestinal complaints, 25 with urticaria, and 25 with growth retardation
were included in the study. As control groups, 25 subjects without any chronic disease but with acute gastrointestinal complaints and 25
healthy volunteers, making a total of 50 subjects, were included in the study. E. intestinalis was investigated by IFA-MAbs and molecular
methods.
Results: Forty percent of patients receiving chemotherapy and with acute gastrointestinal complaints, 24% of patients with bone marrow
transplant and acute gastrointestinal complaints, 20% of patients with urticaria, 40% of children with growth retardation, and 28% of
patients without any chronic disease but with acute gastrointestinal complaints were determined as positive.
Conclusion: To the best of our knowledge, this is the first report to assess the relationship between E. intestinalis and growth retardation.
We think that the reliability of the use of molecular methods, especially real-time PCR, should be improved for the diagnosis of E.
intestinalis.
Key words: Encephalitozoon intestinalis, prevalence, IFA-MAbs, nested PCR, probe-based real-time PCR

1. Introduction
Microsporidian pathogens are obligate intracellular
parasites that infect all ages in humans and animals
and have highly resistant and small spores. Of the more
than 1200 species of microsporidia belonging to 144
genera, 14 species are known to cause human infections.
Encephalitozoon intestinalis, Encephalitozoon hellem,
Encephalitozoon cuniculi, and Enterocytozoon bieneusi are
responsible for over 90% of microsporidia infections in
humans (1,2).
Encephalitozoon intestinalis causes opportunistic
infections in immunocompromised patients. E. intestinalis
may cause enteritis, cholangitis, cholecystitis, nephritis,
bronchitis, sinusitis, rhinitis, and keratoconjunctivitis
and disseminated infection in addition to persistent lifethreatening diarrhea (1,2). It is the second most prevalent
microsporidia species in humans (1,3).
The diagnosis of microsporidiosis is difficult. Light
and fluorescent microscopy and trichrome staining
* Correspondence: syazar@erciyes.edu.tr
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are often used as a routine method for the detection of
microsporidia. The use of molecular methods for the
diagnosis of microsporidian pathogens in recent years has
been accelerated (2,4).
The aim of this study was to investigate the prevalence
of E. intestinalis in different patient groups consisting of
immunocompromised and immunocompetent individuals
with different diagnostic methods and to determine the
sensitivity and specificity of the diagnostic methods used
in this study.
2. Materials and methods
2.1. Patient and control groups
The study was conducted between 2012 and 2014 in
the Erciyes University Medical Faculty Department of
Parasitology. It was performed after being approved
(application deadline: 05.04.2011, decision no: 2011 / 196)
by the Ethics Committee of the Erciyes University Medical
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School. Fecal samples collected from patients admitted
to the Parasitology Laboratory and those of healthy
volunteers were included in this study. Patient groups were
formed according to the clinical diagnosis. The patient and
control groups are given in Table 1.
E. intestinalis was investigated by IFA-MAbs and
molecular methods (nested PCR and probe-based realtime PCR).
2.2. IFA-MAbs
All samples were evaluated by the use of a commercial
kit (Bordier Affinity Products, Switzerland) following the
manufacturer’s instructions.
2.3. Molecular methods
2.3.1. DNA extraction
Stool samples were stored at –20 °C until DNA isolation.
These samples were concentrated with the water-ether
sedimentation method. The precipitate was diluted in
100 µL of distillated water. DNA was prepared using
the QIAmp stool kit (QIAGEN, Germany) with minor
modifications to the manufacturer’s protocol. Briefly, the
pellet was resuspended in 1.4 mL of ASL buffer and 0.250 g
of 425–600 µm acid-washed glass beads (Sigma, USA) was
added. The samples were homogenized in a mini beadbeater (BioSpec, Taiwan) for 2 min at high speed. The
homogenized samples were transferred into 15 mL Falcon
tubes and frozen in liquid nitrogen. The samples were then
put into boiling water and boiled for 5 min. At the end
of the boiling process, the samples were homogenized
in a mini bead-beater for 20 s at high speed. The tubes
were then centrifuged at 20000 × g for 2 min, and the
upper phase of each sample was transferred to a different
tube. For the steps of downstream processing, DNA was
prepared following the manufacturer’s instructions. DNA
was eluted in 100 µL of AE buffer and stored at –20 °C
until applied for PCR.
2.3.2. Nested PCR
First PCR reactions were performed with Micro-F and
Micro-R primers (5). These primers were amplified

to approximately 1300 bp 16S SSU rRNA fragments.
Secondary PCR reactions used SINTF1 and SINTR
primers to amplify approximately 530 bp 16S SSU rRNA
fragments (6). Both PCR steps were performed in a 25
µL volume containing 20 pmol of each primer, 200 mM
concentrations of each deoxynucleoside triphosphate
(dNTP), 2 mM MgCl2, and 5 U of Taq DNA polymerase.
The primary PCR program consisted of an initial
denaturation at 95 °C for 15 min; 45 cycles of denaturation
at 94 °C for 60 s, annealing at 54 °C for 90 s, and elongation
at 72 °C for 90 s; and a final elongation at 72 °C for 10 min.
The secondary PCR program consisted of an activation
step at 95 °C for 5 min and 30 cycles of denaturation at 94
°C for 30 s, annealing at 52 °C for 30 s, and elongation at
72 °C for 60 s with a final elongation at 72 °C for 7 min.
2.3.3. Primer design and real-time PCR
We designed novel primers to amplify 62 bp 16S SSU
rRNA fragments and probe as follows: E.int F (5’ cctgactggacggacagaag - 3’), E.int R (5’ - ttcgtccttcatcgtcacat
- 3’), and Universal ProbeLibrary (UPL) probe (Roche Cat.
No. 04692179001; ctgtgctc) (Figure 1).
Amplifications were done in 20 µL reaction mixtures
under the following conditions: 20 pmol of each primer,
0.4 µL UPL probe, 1X probe master, and 5 µL of DNA. The
real-time PCR program consisted of an initial denaturation
at 95 °C for 10 min, followed by 45 cycles at 95 °C for 10 s,
60 °C for 30 s, and 72 °C for 1 s with a final cooling at 40
°C for 30 s.
Dilution series of different concentrations that were
prepared from plasmids containing the gene region of E.
intestinalis 16S SSU rRNA and genomic DNA that DNA
sequence analysis had confirmed as E. intestinalis were
used as positive controls. Sterile distilled water; plasmids
containing the gene region of E. cuniculi, E. hellem, and
E. bieneusi 16S SSU rRNA; and genomic DNA samples
that were positive for Giardia intestinalis, Cryptosporidium
parvum, Blastocystis hominis, Toxoplasma gondii, and
Leishmania spp. were used as negative controls.

Table 1. Patient and control groups
Groups

Disease condition

GD*

Sex (M/F)

Average age

Diarrhea (+/-)

Total

Oncology

Receiving chemotherapy

+

13/12

62.52 ± 11.36

20/5

25

BMT**

BMT

+

18/7

42.4 ± 13.42

20/5

25

Urticaria

Urticaria

-

11/14

34.66 ± 14.56

0/25

25

Growth retardation

Growth retardation

-

10/15

8.16 ± 3.42

3/22

25

Control 1

Without chronic illness

+

12/13

46.88 ± 16.08

12/13

25

Control 2

Healthy volunteers

-

15/10

29.77 ± 9.9

0/25

25

*GD: Gastrointestinal disorders, **BMT: Bone marrow transplantation.
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Figure 1. Encephalitozoon intestinalis-specific primers and probe.

2.4. Statistical analysis
The chi-square exact test was applied for the comparison
of categorical variables. Multiple comparisons of chisquare tests were made with the Bonferroni correction
Z-test. The normal distribution of numerical variables
was inspected with the Shapiro–Wilk normality test. For
two groups a comparison with independent samples was
performed with the t-test and two-group comparisons
were performed with one-way variance analysis. Turkey’s
HDS test was used for a multiple comparison test and P <
0.05 was considered statistically significant.
3. Results
3.1. Specificity and sensitivity of probe-based real-time
PCR
The sensitivity of the probe-based real-time PCR reaction
was tested by using serial dilutions prepared from plasmids
containing the gene region of E. intestinalis 16S SSU rRNA
(Figure 2). No amplification (Ct > 40) was obtained with
plasmids that contained the gene region of E. cuniculi, E.
hellem, and E. bieneusi 16S SSU rRNA; from genomic DNA
samples that were positive for G. intestinalis, C. parvum,
B. hominis, T. gondii, and Leishmania spp.; or from sterile
distilled water.
3.2. Prevalence of Encephalitozoon intestinalis
The positivity rate of E. intestinalis on the basis of
the results obtained with probe-based real-time PCR
was identified. The distribution of E. intestinalis was
investigated according to sex, age, research groups, and
diarrhea (Table 2).
As can be seen in Table 2, no significant differences
were found regarding E. intestinalis infection between
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sexes (P = 0.459) and diarrhea presence (P = 0.241).
There was a statistically significant relationship between
E. intestinalis infection and age groups (P = 0.007). E.
intestinalis infection was found higher in the age groups
of 0–17, 41–50, and 51–60 but it was not found in the
31–40 age group. There was also a relationship between E.
intestinalis infection and the research groups (P = 0.043).
The lowest rate of E. intestinalis infection was in control
group II, namely the healthy volunteers. The highest rate of
E. intestinalis infections was in the oncology patients and
children with growth retardation.
3.3. Encephalitozoon intestinalis load in stool samples
Parasitic load was calculated based on the crossing point
(Cp) values that were obtained as a result of real-time PCR
analysis. The Cp values according to sex, age, research
groups, and diarrhea and statistical analysis are given in
Table 3.
As can be seen in Table 3, no significant differences
were found regarding the parasitic load among sexes (P =
0.346), age (P = 0.619), and diarrhea condition (P = 0.163).
There was also a relationship between the parasitic load
and research groups (P = 0.000). The highest parasitic load
was in control group I.
3.4. Evaluation of the sensitivity and specificity of IFAMAbs and nested PCR for detection of Encephalitozoon
intestinalis
According to the results obtained with probe-based realtime PCR, the sensitivity and specificity of IFA-MAbs
and nested PCR for the detection of E. intestinalis were
determined (Table 4). Twelve (8%) and 29 (19%) of 150
patients were evaluated as positive by nested PCR (Figure
3) and IFA-MAbs (Figure 4), respectively.
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Figure 2. Analysis by probe-based real-time PCR of serial dilutions prepared from plasmids that contain the gene region
of E. intestinalis 16S SSU rRNA. A) Amplification curve. B) Standard curve.

Twelve (8%) patients were found to be positive by both
nested PCR and real-time PCR, while 27 (10%) patients
were found to be positive only by real-time PCR. When
the probe-based real-time PCR test was accepted as a
reference, it was found that nested PCR had a positive
predictive value of 100%, a negative predictive value of
80.4%, sensitivity of 30.8%, and specificity of 100%.
Twenty-two (14.7%) patients were found to be positive
by both IFA-MAbs and real-time PCR, while 17 (11.3%)
patients were found to be positive by only real-time PCR.
When the probe-based real-time PCR test was accepted
as a reference, it was found that IFA-MAbs had a positive
predictive value of 75.9%, a negative predictive value of
86%, sensitivity of 56.4%, and specificity of 93.7%.
4. Discussion
The spores of E. intestinalis cannot be identified by
conventional stool examination methods because of their

small size; therefore, there is a need for different diagnostic
methods (1,2,7). Monoclonal antibodies are one of the
methods used for diagnosis. This method is accepted as the
gold standard by some researchers for the diagnosis of E.
intestinalis because it is faster and cheaper than PCR (8,9).
However, some researchers assert that samples evaluated
as positive with IFA-MAbs need to be confirmed by other
methods (10,11). In recent years, many researchers have
preferred to use molecular methods for diagnosis (12–15).
In our study, nested PCR and real-time PCR methods were
used. According to the obtained results, we determined
that there were no false negative results by nested PCR.
However, when compared with real-time PCR, the
sensitivity of nested PCR was quite low. Many researchers
have reported that probe-based real-time PCR methods
have 100% sensitivity and specificity. It was reported that
102 spores/mL in stool can be detected by probe-based
real-time PCR methods (12–16). Therefore, in the present
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Table 2. The distribution of E. intestinalis according to sex, age, research groups, and diarrhea.

Group

Groups

Diarrhea

Age

Sex

Male

Positive

Negative

Total

n (%)

n (%)

n (%)

18 (22.8)

61 (77.2)

79 (52.7)

Female

21 (29.6)

50 (70.4)

71 (47.3)

Total

39 (26)

111 (74)

150 (100)

0–17 (n: 25)

10 (40)

15 (60)

25 (16.7)

18–30 (n: 37)

7 (18.9)

30 (81.1)

37 (24.7)

31–40 (n: 23)

-

23 (100)

23 (15.3)

41–50 (n: 22)

7 (31.8)

15 (68.2)

22 (14.7)

51–60 (n: 21)

10 (47.6)

11 (52.4)

21 (14)

>61 (n: 22)

5 (22.7)

17 (77.3)

22 (14.7)

Total

39 (26)

111 (74)

150 (100)

Positive

18 (33.3)

36 (66.7)

54 (36)

Negative

21 (21.9)

75 (78.1)

96 (64)

Total

39 (26)

111 (74)

150 (100)

Oncology (n: 25)

10 (40)

15 (60)

25 (16.7)

*BMT (n: 25)

6 (24)

19 (76)

25 (16.7)

Urticaria (n: 25)

5 (20)

20 (80)

25 (16.7)

Growth retardation (n: 25)

10 (40)

15 (60)

25 (16.7)

Control 1 (n: 25)

7 (28)

18 (72)

25 (16.7)

Control 2 (n: 25)

1 (4)

24 (96)

25 (16.7)

Total

39 (26)

111 (74)

150 (100)

*BMT: Bone marrow transplantation, Control 1: Patients with acute gastrointestinal
complaints but without any chronic disease, Control 2: Healthy volunteers.

study, the results were achieved with probe-based realtime PCR.
Microsporidian pathogens are opportunistic pathogens
and are most commonly found in immunocompromised
patients (1,3). They can also cause serious infections in
patients receiving chemotherapy and in bone marrow
transplant patients and may have an adverse effect on
the treatment process (17–20). In this study, it was found
that E. intestinalis was prevalent in patients receiving
chemotherapy (40%) and in bone marrow transplant
patients admitted with acute gastrointestinal complaints
(24%). It should be remembered that E. intestinalis appears
to have a primary infection site in the small bowel, but it has
also been found in the duodenum, jejunum, ileum, colon,
kidney, liver, and gallbladder and other sites, including the
lower respiratory tract (1–3). This situation can adversely
affect both the patient’s quality of life and the treatment
process. We think that patients receiving chemotherapy
and bone marrow transplant patients, especially those with

1054

gastrointestinal complaints, should be regularly evaluated
in terms of E. intestinalis to improve the quality of life and
to protect them from parasitic infections.
One of our research groups included patients with
urticaria. Urticaria is a skin disease that can appear as red,
itchy, swollen areas of the skin that can range in size; it
can occur anywhere on the body but is mainly found on
the trunk, arms, or legs. Urticaria is defined as chronic
when it persists for longer than 6 weeks. The etiology is
unknown in approximately 70% of chronic urticaria cases.
Sensitivity to nutrients takes first place among the causes
identified (21,22). Studies on the role of parasites in the
etiology of urticaria have shown that the most responsible
protozoa are G. intestinalis and B. hominis (23,24). The
number of studies on the role of microsporidian pathogens
in the etiology of urticaria is quite low. We found only
one study conducted so far, in which the incidence of
microsporidian pathogens was reported as 19.7%, but
it did not specify species (25). No data have been found
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Table 3. Crossing point values according to sex, age, research groups, and diarrhea and statistical analysis.
Number of
positive patients

Crossing point values
Min–max

Average

SD

Male (n: 79)

18

29.78–38.29

33.88

1.78

Female (n: 71)

21

27.63–36.86

33.21

2.82

0–17 (n: 25)

10

29.27–36.31

34.35

2.07

Groups

Diarrhea

Age

Sex

Group

18–30 (n: 37)

7

30.54–36.86

33.79

2.21

31–40 (n: 23)

-

-

-

-

41–50 (n: 22)

7

29.78–38.29

33.14

2.87

51–60 (n: 21)

10

28.65–36.22

33.40

2.37

>61 (n: 22)

5

27.63–34.98

32.25

3.39

Positive (n: 54)

18

27.63–34.95

32.9

2.45

Negative (n: 96)

21

28.65–38.29

34

2.45

Oncology (n: 25)

10

33.55–34.95

34.55

0.9

*BMT (n: 25)

6

31.77–34.8

33.25

1.21

Urticaria (n: 25)

5

32.51–38.29

35.23

2.42

Growth retardation (n: 25)

10

29.27–36.31

34.35

2.07

Control 1 (n: 25)

7

27.63–30.94

29.56

1.12

Control 2 (n: 25)

1

-

-

-

F

P

33.818

0.346

0.667

0.619

36

0.163

13.501

0.000

*BMT: Bone marrow transplantation, Control 1: Patients with acute gastrointestinal complaints but without any chronic disease,
Control 2: Healthy volunteers.
Table 4. Sensitivity and specificity of IFA-MAbs and nested PCR for detection of Encephalitozoon
intestinalis.
Real-time PCR

Methods
IFA-MAbs
Nested PCR

Positive

Negative

Positive

22

7

Negative

17

104

Positive

12

-

Negative

27

111

in the literature concerning the relationship between E.
intestinalis and urticaria. In this study, it was found that E.
intestinalis was prevalent in patients with urticaria (20%).
It is very important to determine the cause of urticaria,
which adversely affects the activities of daily living and
quality of life of patients, in order to give the correct
therapy. Intestinal parasites also cause various symptoms
in the nervous system, the urogenital tract, and the skin,
in addition to gastrointestinal complaints. At the same
time, it should be remembered that E. intestinalis can also
cause infections in immunocompetent individuals (1–3),

Sensitivity

Specificity

56.4%

93.7%

30.8%

100%

and patients with urticaria, especially of unknown cause,
should be regularly evaluated in terms of E. intestinalis.
Another of our research groups included children
with growth retardation. Growth and developmental
retardation occur due to various reasons such as
eating disorders, malabsorption, intestinal parasites,
hormonal reasons, family reasons, and chronic diseases.
Intestinal parasites can cause malnutrition in addition to
gastrointestinal disorders such as vomiting, diarrhea, and
appetite changes and may lead to failure in the physical
and mental development of the child (26). Although
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Figure 3. Agarose gel showing amplifications of nested PCR of E. intestinalis. M: 100-bp Plus DNA Ladder;
lane 1: positive control, lane 2: negative control; lanes 3, 6–8, 11, 12: E. intestinalis-positive samples; 4, 5, 9, 10:
E. intestinalis-negative samples.

microsporidian pathogens have been reported in children
in previous studies (27–29), to the best of our knowledge,
this is the first report to assess the relationship between
E. intestinalis and growth retardation. In our study, it was
found that E. intestinalis was prevalent in children with
growth retardation (40%). We think that it is necessary to
evaluate children with growth retardation in terms of E.
intestinalis regardless of the presence of gastrointestinal
complaints.
Another of our research groups included patients
with acute gastrointestinal complaints but without any
chronic disease. The most typical symptoms of intestinal
microsporidiosis are watery diarrhea (without blood
and leukocytes), loss of appetite, and weight loss. As a
result of the development of diagnostic methods and
increasing awareness, it has been established that E.
intestinalis may cause acute and self-limiting diarrhea
not only in immunocompromised patients but also in

Figure 4. E. intestinalis spores in positive sample with IFA-MAbs
(1000×).
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immunocompetent individuals. Therefore, many studies
concerning E. intestinalis have focused on patients
with gastrointestinal complaints (1–3). Microsporidian
pathogens were reported to have a prevalence ranging from
6.5% to 83% in studies in patients with diarrhea (30–34).
In the present study, it was found that E. intestinalis was
prevalent in patients with acute gastrointestinal complaints
but without any chronic disease (28%). Diarrhea is a
clinical condition that adversely affects people’s daily
activities and causes a large amount of fluid and electrolyte
loss. Determining the cause of diarrhea is very important
for proper treatment. We think that patients with acute
and chronic gastrointestinal complaints but without
any chronic disease should be evaluated in terms of E.
intestinalis.
In conclusion, E. intestinalis was found to be common
not only in immunocompromised patients but also in
children with growth failure, in patients with urticaria,
and in patients with acute gastrointestinal complaints.
In nested PCR, which has low sensitivity, the probability
of false-negative results is high, while in IFA-MAbs,
which has low sensitivity and specificity, the probability
of false-negative or false-positive results is high. One of
the most important limitations of this study is that each
study group was composed of only 25 patients. At the
same time, the relationships between sociodemographic
factors/patients’ symptoms and the presence of parasites/
parasite load were not demonstrated in detail. In future
studies the relationship between these factors and E.
intestinalis should be investigated in detail. We think that
E. intestinalis should be investigated in other diseases,
especially in diseases of unknown cause.
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